Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Lophocereus marginatus extracts may help treat melanoma and stimulate hair growth.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

VB-1, a natural compound, may promote hair growth by enhancing a key cell growth pathway.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

New acne treatments show promise as alternatives to traditional therapies.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Hair loss in women may have causes other than hormones.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.